Do Changes in Trauma-Related Beliefs Predict PTSD Symptom Improvement in Prolonged Exposure and Sertraline?

被引:39
作者
Cooper, Andrew A. [1 ,6 ,7 ]
Zoellner, Lori A. [2 ,3 ]
Roy-Byrne, Peter [2 ,3 ]
Mavissakalian, Matig R. [4 ]
Feeny, Norah C. [5 ]
机构
[1] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA
[2] Univ Washington, Dept Psychol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA
[4] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA
[6] Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada
[7] Univ Toronto Scarborough, Grad Dept Clin Psychol Sci, Scarborough, ON, Canada
关键词
PTSD; exposure; selective serotonin reuptake inhibitors; sertraline; beliefs; process of change; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; COGNITIVE THERAPY; PSYCHOLOGICAL TREATMENTS; MECHANISMS; ANXIETY; EFFICACY; FEAR; PSYCHOTHERAPY; INVENTORY;
D O I
10.1037/ccp0000220
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Negative trauma-related belief change has been found to predict subsequent improvement in symptoms of posttraumatic stress disorder (PTSD) in prolonged exposure (PE) and other therapies, consistent with several psychological theories of treatment change (e.g., Foa & Kozak, 1986). However, belief change has not been examined in selective serotonin reuptake inhibitors such as sertraline. We examined processes associated with symptom improvement in 2 treatments for PTSD, hypothesizing that belief change would robustly predict PTSD improvement in patients treated with PE but not those treated with sertraline, reflecting moderation by treatment. Method: Patients with chronic PTSD (N = 134; 78% women, 71.6% Caucasian, M = 38.1 years, SD = 11.8) received 10 weeks of PE or sertraline in a randomized, controlled trial. Patients reported PTSD and depression symptoms, and trauma-related beliefs (Post-Traumatic Cognitions Inventory; Foa, Ehlers, Clark, D Tolin, & Orsillo, 1999) at pretreatment, every treatment session, and posttreatment. Results: Using time-lagged mixed regression models, change in trauma-related beliefs predicted subsequent PTSD symptom improvement, an effect moderated by treatment and particularly strong in PE (d = 0.93) compared with sertraline (d = 0.35). Belief change also predicted depressive symptom improvement but more modestly and bidirectionally, with no difference by treatment modality. Conclusions: Trauma-related belief change precedes PTSD improvement more robustly in PE than in sertraline and with greater specificity compared with depressive symptoms. These findings highlight potentially divergent processes contributing to symptom change in these PTSD treatments, with belief change as a key mechanism of PE. What is the public health significance of this article? Changing trauma-related negative beliefs may be an important pathway to PTSD symptom improvement for cognitive-behavioral psychotherapies such as prolonged exposure (PE) but is perhaps less central for pharmacotherapy using selective serotonin reuptake inhibitors (SSRIs). Consistent with specificity to PTSD, there was less evidence for the role of change in trauma-related beliefs for depression symptoms. Processes that promote symptom improvement may differ between PE and SSRIs whereby change in PE may occur through specific learning processes surrounding adaptively shifting views about oneself, the world, and others.
引用
收藏
页码:873 / 882
页数:10
相关论文
共 82 条
[41]   Mediators and mechanisms of change in psychotherapy research [J].
Kazdin, Alan E. .
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, 2007, 3 :1-27
[42]   Investigating Cognitive Pathways to Psychopathology: Predicting Depression and Posttraumatic Stress Disorder From Early Responses After Assault [J].
Kleim, Birgit ;
Ehlers, Anke ;
Glucksman, Edward .
PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2012, 4 (05) :527-537
[43]   Cognitive Change Predicts Symptom Reduction With Cognitive Therapy for Posttraumatic Stress Disorder [J].
Kleim, Birgit ;
Grey, Nick ;
Wild, Jennifer ;
Nussbeck, Fridtjof W. ;
Stott, Richard ;
Hackmann, Ann ;
Clark, David M. ;
Ehlers, Anke .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2013, 81 (03) :383-393
[44]   Temporal Sequencing of Change in Posttraumatic Cognitions and PTSD Symptom Reduction During Prolonged Exposure Therapy [J].
Kumpula, Mandy J. ;
Pentel, Kimberly Z. ;
Foa, Edna B. ;
LeBlanc, Nicole J. ;
Bui, Eric ;
McSweeney, Lauren B. ;
Knowles, Kelly ;
Bosley, Hannah ;
Simon, Naomi M. ;
Rauch, Sheila A. M. .
BEHAVIOR THERAPY, 2017, 48 (02) :156-165
[45]   Path analytic examination of a cognitive model of PTSD [J].
Lancaster, Steven L. ;
Rodriguez, Benjamin F. ;
Weston, Rebecca .
BEHAVIOUR RESEARCH AND THERAPY, 2011, 49 (03) :194-201
[46]   BIO-INFORMATIONAL THEORY OF EMOTIONAL IMAGERY [J].
LANG, PJ .
PSYCHOPHYSIOLOGY, 1979, 16 (06) :495-512
[47]   PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS [J].
Lee, Daniel J. ;
Schnitzlein, Carla W. ;
Wolf, Jonathan P. ;
Vythilingam, Meena ;
Rasmusson, Ann M. ;
Hoge, Charles W. .
DEPRESSION AND ANXIETY, 2016, 33 (09) :792-806
[48]   Cognitive factors in the development, maintenance, and treatment of post-traumatic stress disorder [J].
LoSavio, Stefanie T. ;
Dillon, Kirsten H. ;
Resick, Patricia A. .
CURRENT OPINION IN PSYCHOLOGY, 2017, 14 :18-22
[49]   The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? [J].
MacQueen, G. ;
Frodl, T. .
MOLECULAR PSYCHIATRY, 2011, 16 (03) :252-264
[50]   Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study [J].
Marshall, RD ;
Beebe, KL ;
Oldham, M ;
Zaninelli, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (12) :1982-1988